Sinovac Provides Update On Study Of Third Dose Of Its Pandemic Influenza Vaccine
Wed, 07 Mar 2007 08:00 AM EST
... Sinovac Biotech Ltd. (Amex: SVA), a leading provider of biopharmaceutical products in China, today announced an update for the study evaluating the third dose of its vaccine against the H5N1 dose of pandemic influenza. [click link for full article] ...
Related Topics
- Influenza
- Vaccine
- Influenza Virus Vaccine
- Vaccine Side Effects
- Avian Influenza
- Polio Vaccine & Cancer
- Polio Vaccine
- Polio Vaccine & Origin of HIV/AIDS
- Influenza (flu) Vaccine
- Influenza Virus Intranasal Vaccine
- MMR Vaccine & (Asceptic) Meningitis
- Influenza and Colds
- Smallpox Vaccine
- Chickenpox Vaccine
- Hepatitis A Vaccine
- Hepatitis A and Hepatitis B Vaccine
- Hepatitis B Vaccine
- Pneumococcal Vaccine
- Methylprednisolone
- Anthrax Vaccine

Not Signed In -


